Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 408-090-7 | CAS number: 100418-33-5 METHYLGELB
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 2-((4-methyl-2-nitrophenyl)amino)ethanol
- EC Number:
- 408-090-7
- EC Name:
- 2-((4-methyl-2-nitrophenyl)amino)ethanol
- Cas Number:
- 100418-33-5
- Molecular formula:
- C9H12N2O3
- IUPAC Name:
- 2-[(4-methyl-2-nitrophenyl)amino]ethan-1-ol
- Test material form:
- solid: crystalline
- Details on test material:
- red powder
Batch # : 6718 Fass 10/20
Constituent 1
- Specific details on test material used for the study:
- Hydroxyethyl-2-nitro-p-toluidine (B075) tested at a concentration of 1 % in a commercial hair dye formulation.
- Radiolabelling:
- no
Test animals
- Species:
- other: human
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Full-thickness human skin samples (5 abdomen and 1 breast) were obtained from six patients aged 30 to 63 years old. The samples were obtained from patients attending the NHS Lothian, St Johns Hospital, Livingston, UK. All patients gave informed consent prior to undergoing surgery, for their excised skin to be used for scientific purposes. The skin was transferred to Charles River on ice, where it was cleaned of subcutaneous fat and connective tissue using a scalpel blade. The skin samples were washed in cold running water and dried using tissue paper. The skin samples were then cut into smaller pieces (where appropriate), wrapped in aluminium foil and placed into self sealing plastic bags. All skin samples were stored at ca -20°C until used in the study. The age and sex of the donor and site from which the skin was taken, were recorded centrally and in the study records.
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- other:
- Duration of exposure:
- Receptor fluid was collected in 30 min fractions from 0 to 1 h post dose and hourly fractions
from 1 to 6 h post dose and then in 2 hourly fractions from 6 to 72 h post dose. - Doses:
- Non-Oxidative Conditions test Preparation 1 (1%, w/w)
Oxidative Conditions Test Preparation 2 (1%, w/w)
Results and discussion
- Signs and symptoms of toxicity:
- not examined
- Dermal irritation:
- not specified
- Total recovery:
- Test Preparation 1 96.85%
Test Preparation 2: 98.32%
Percutaneous absorptionopen allclose all
- Time point:
- 72 h
- Dose:
- Test Preparation 1 (1%, w/w)
- Parameter:
- percentage
- Absorption:
- 3.08 %
- Time point:
- 72 h
- Dose:
- Test Preparation 2 (1%, w/w)
- Parameter:
- percentage
- Absorption:
- 2.14 %
Applicant's summary and conclusion
- Conclusions:
- In conclusion, following topical application of B075 in hair dye Test Preparations 1 and 2 (both 1%, w/w) to human skin in vitro, at 72 h post dose, the absorbed dose of B075 or the amount that had penetrated through the skin into the receptor fluid, was 3.08 μg/cm2 and 3.96 μg/cm2, respectively. The epidermis contained 0.01 μg/cm2 and 0.01 μg/cm2, respectively. The dermis contained 0.03 μg/cm2 and 0.08 μg/cm2, respectively.
- Executive summary:
Hydroxyethyl-2-nitro-p-toluidine (B075, WR20883) is a hair dye molecule used in hair dye formulations. As part of the safety evaluation of B075, a study was required to assess the rate and extent of absorption of B075 following topical application of B075 to human skin, under in-use conditions. B075 was supplied ready-formulated in a typical hair dye formulation at 1% (w/w) for testing under non-oxidative conditions (Test Preparation 1). Additionally, for testing under oxidative conditions, a typical hair dye formulation containing 2% (w/w) B075 was mixed with peroxide developer (1:1, w/w, Test Preparation 2). Thereafter, the concentration of B075 in Test Preparation 2 applied to the skin was 1% (w/w). Split-thickness human skin membranes were mounted into flow-through diffusion cells. Receptor fluid, phosphate buffered saline containing sodium azide (ca 0.01%, w/v), was pumped underneath the skin at a flow rate of ca 1.5 mL/h. The skin surface temperature was maintained at ca 32°C throughout the experiment. A tritiated water barrier integrity test was performed and any human skin sample exhibiting absorption greater than 0.6% of the applied dose after 1 h was excluded from subsequent absorption measurements. Two test preparations containing B075 were applied, at an application rate of ca 20 mg test preparation/cm2, to human split-thickness skin membranes mounted into flow-through
diffusion cells in vitro. At 30 min post dose, the skin was washed with water, sodium dodecyl sulphate (SDS) solution (2% w/v) and water again. The skin was then dried with tissue paper swabs. The study was conducted according to the OECD principles of Good Laboratory Practice as set forth by the United Kingdom Department of Health and was performed following the SCCP, COLIPA and OECD Test Guideline No. 428 and the accompanying OECD Guidance Document No. 28. Absorption was assessed by collecting receptor fluid in 30 min fractions from 0 to 1 h post dose, then hourly fractions from 1 to 6 h post dose and then in 2-hourly fractions from 6 to 72 h post dose. At 72 h post dose, the skin surface was washed and dried in the same manner as described for the 30 min wash. The underside of the skin was rinsed with receptor fluid. The skin was then removed from the flow-through cells, dried and the skin divided into
exposed and unexposed skin (ie the area of skin under the cell flange). The stratum corneum from the exposed skin was removed by tape stripping. The exposed epidermis was separated from the dermis. All samples were analysed by LC-MS/MS. Following topical application of B075 in Test Preparation 1 (1%, w/w) to human skin in vitro, at 72 h post dose, the absorbed dose of B075 or the amount that had penetrated through the skin into the receptor fluid, was 1.55% (3.08 μg/cm2) of the applied dose. The epidermis contained <0.01% (0.01 μg/cm2) of the applied dose. The dermis contained 0.01% (0.03 μg/cm2) of the applied dose. For Test Preparation 1, the majority of the B075 was removed at 30 min post dose by washing the skin surface (94.83%). The mass balance was essentially complete (96.85%). These results are based on 9 samples of skin from 4 different donors Following topical application of B075 in Test Preparation 2 (1%, w/w) to human skin in vitro, at 72 h post dose, the absorbed dose of B075 or the amount that had penetrated through the skin into the receptor fluid, was 2.14% (3.96 μg/cm2) of the applied dose. The epidermis contained <0.01% (0.01 μg/cm2) of the applied dose. The dermis contained 0.04% (0.08 μg/cm2) of the applied dose. For Test Preparation 2, the majority of the B075 was removed at 30 min post dose by washing the skin surface (95.64%). The mass balance was essentially complete (98.32%). These results are based on 10 samples of skin from 4 different donors. In conclusion, following topical application of B075 in hair dye Test Preparations 1 and 2 (both 1%, w/w) to human skin in vitro, at 72 h post dose, the absorbed dose of B075 or the amount that had penetrated through the skin into the receptor fluid, was 3.08 μg/cm2 and 3.96 μg/cm2, respectively. The epidermis contained 0.01 μg/cm2 and 0.01 μg/cm2,
respectively. The dermis contained 0.03 μg/cm2 and 0.08 μg/cm2, respectively.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.